Safest Compounded Tirzepatide Providers in 2026: A Pharmacovigilance Ranking

1. Peak Wellness Network: Top Safety Pick

Peak Wellness is the only top-three provider that earns its rank without a third-party Trustpilot or BBB profile. Read alongside four named 503A partners and a clean regulator record, that absence lands as a safety signal rather than a gap.

Get Started With Peak Wellness

Quick Facts

What I Liked

1. Four named 503A pharmacy partners with state/city: Emerald Compounding (Tampa FL), Epiq Scripts (Richardson TX), Southend Pharmacy (Houston TX), AbsoluteRx (Lutz FL).
2. No active Eli Lilly lawsuit, no NAD action, no FDA warning letter.
3. Flat pricing - no membership fees, no escalation upcharges at higher doses.
4. Clinical review within 24 hours via Dr. TelX with board-certified obesity-medicine oversight.
5. Direct site, no affiliate redirect chain.

Room for Improvement

1. No third-party BBB or Trustpilot profile under trypeak.com surfaces in standard search as of May 2026, leaving patients without an independent customer-feedback signal.
2. Cold-chain SOP language on the public site is thin. Shipping is described as "48-72 hours from a state-regulated pharmacy in discreet packaging," with no temperature-monitoring or storage-procedure detail.
3. Domain confusion with peakwellnesspa.com (a Pennsylvania medical practice) and trtpeak.com (a separate TRT clinic) creates verification friction for patients searching the brand name.

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 9/10 - four named partners, all verifiable through state pharmacy boards
• Adverse Event Response (25%): 7/10 - no negative third-party signal, no positive third-party signal
• Cold-Chain & Medication Handling (20%): 6/10 - clean record, undisclosed SOP
• Clinical Oversight (15%): 7/10 - 24-hour async with named provider group
• Marketing & Regulatory Posture (10%): 9/10 - no flags
• Weighted composite: 7.4/10

Includes

• Initial lab test: not specified
• Membership fee: none
• Coaching: not specified
• Doctor consultations: async (24-hour review)
• Shipping: included (48-72 hours, state-regulated pharmacy)

Get Started With Peak Wellness

2. OnlineSemaglutide.org: Strongest Documented Compliance

The newest provider in this lineup, launched June 2025, carries the most documentation on the safety axes that matter most.

Get Started With OnlineSemaglutide.org

Quick Facts

What I Liked

1. Four named 503A pharmacy partners on the About page: Belmar, Strive, Epiq Scripts, Casa Pharma Rx.
2. LegitScript Certified per company disclosures, providing third-party verification of regulatory compliance.
3. Hybrid clinical model: secure video or async chat with a board-certified clinician.
4. Each batch undergoes third-party potency and sterility testing per partner-pharmacy disclosures.
5. Temperature-controlled packaging language explicitly references FDA and USP standards.

Room for Improvement

1. Brand is less than one year old, leaving limited longitudinal patient outcomes data and no aged third-party rating to anchor the AE-response axis.
2. No Trustpilot or BBB profile found in standard search as of May 2026, which means no third-party customer-feedback aggregation yet.
3. Compounded products are not FDA-approved, a universal disclaimer that applies across the category but should be read alongside the LegitScript certification.

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 9/10 - all four 503A partners named, post-March 2025 compliant
• Adverse Event Response (25%): 6/10 - no profile yet, but no negative signal
• Cold-Chain & Medication Handling (20%): 8/10 - documented SOP plus third-party batch testing
• Clinical Oversight (15%): 8/10 - hybrid sync video + async clinical model
• Marketing & Regulatory Posture (10%): 8/10 - LegitScript Certified, no lawsuits, no NAD action
• Weighted composite: 7.0/10

Includes

• Initial lab test: not specified
• Membership fee: none
• Coaching: not specified
• Doctor consultations: hybrid (sync video or async chat)
• Shipping: temperature-controlled packaging (price not specified separately)

Get Started With OnlineSemaglutide.org

3. GobyMeds: Best Third-Party Validated Record

GobyMeds is the only provider in the lineup with an investment-grade BBB rating: parent Goby Health LLC carries a B+ with one resolved complaint in three years.

Get Started With GobyMeds

Quick Facts

What I Liked

1. B+ BBB with one complaint in three years and zero unanswered, per the BBB snapshot used for this audit.
2. Trustpilot 4.4 across roughly 196 reviews with no inauthentic-review notice, per Trustpilot at the time of writing.
3. Four named pharmacy partners (CasaPharma RX, Seven Cells, Vital RX, BPI Labs) with the dispensing pharmacy disclosed at intake.
4. Most affordable starter bundle in the lineup at ~$133/month effective on the 12-week plan.
5. Clean regulatory record - no Lilly lawsuit, no NAD action, no FDA warning letter.

Room for Improvement

1. Stock shortage and shipment delay complaints recur in Trustpilot reviews, particularly around the timing of refill consultations, per Trustpilot at the time of writing.
2. Cold-chain SOP is not detailed publicly. Patients see clean reviews but no documented temperature-monitoring protocol.
3. Mixed 503A/503B network requires patients to verify the 503A side is the one filling tirzepatide post-March 19, 2025.

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 8/10 - four named partners, dispensing pharmacy disclosed at intake
• Adverse Event Response (25%): 8/10 - B+ BBB plus responsive Trustpilot pattern
• Cold-Chain & Medication Handling (20%): 5/10 - clean but undisclosed; some delay complaints
• Clinical Oversight (15%): 6/10 - async telehealth with licensed providers
• Marketing & Regulatory Posture (10%): 8/10 - clean
• Weighted composite: 6.5/10

Includes

• Initial lab test: not specified
• Membership fee: none
• Coaching: not specified
• Doctor consultations: async
• Shipping: not specified separately

Get Started With GobyMeds

4. Shed: Large Review Base, Transparency Gap

Trustpilot 4.0 across roughly 902 reviews is the largest third-party data sample in the lineup, and the rating holds up. The drag on the ranking is what is missing from the disclosure.

Get Started With Shed

Quick Facts

What I Liked

1. Trustpilot 4.0 across roughly 902 reviews, the largest third-party sample in the lineup, per Trustpilot at the time of writing.
2. No inauthentic-review notice on the Trustpilot page, per Trustpilot at the time of writing.
3. No Lilly lawsuit, no NAD action, no FDA warning letter.
4. Publishes its own 503A vs 503B explainer content, which suggests staff understand the post-March 2025 regulatory framework.
5. BBB profile shows engagement with no F rating surfaced in May 2026 search, per the BBB snapshot used for this audit.

Room for Improvement

1. Pharmacy partners are not publicly named on product pages, which is a significant gap on the 30%-weighted 503A axis.
2. Negative reviews concentrate on billing-cycle complaints, including charges before shipment, per Trustpilot at the time of writing.
3. Cold-chain SOP is not detailed anywhere on the public site.

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 5/10 - states 503A use, does not name partners
• Adverse Event Response (25%): 7/10 - Trustpilot 4.0 across 902 reviews
• Cold-Chain & Medication Handling (20%): 5/10 - undisclosed
• Clinical Oversight (15%): 5/10 - async telehealth
• Marketing & Regulatory Posture (10%): 7/10 - no flags
• Weighted composite: 5.5/10

Includes

• Initial lab test: not specified
• Membership fee: not specified
• Coaching: not specified
• Doctor consultations: async
• Shipping: not specified

Get Started With Shed

5. Pomegranate: F BBB + Documented Warm-Vial Complaints

Pomegranate is the inflection point in this ranking. It is the first provider where documented safety failures outweigh the disclosed pharmacy network on the weighted score.

See Pomegranate Pricing

Quick Facts

What I Liked

1. Pharmacy partners disclosed on site (BPI Labs and The Pharmacy Hub).
2. Optional B6 add-in formulation marketed for nausea management.
3. Tirzepatide + B6 starter price at $179/month is among the lowest in the field.
4. Trustpilot rating around 4.1, with the majority of reviews skewing five-star, per Trustpilot at the time of writing.
5. No active Eli Lilly lawsuit on the docket as of this audit.

Room for Improvement

1. BBB rating: F, attributed primarily to a failure-to-respond pattern, per a search-aggregated BBB excerpt (direct fetch was blocked at the time of writing).
2. Documented warm-vial shipment complaints on Trustpilot, per Trustpilot at the time of writing. Customers describe compounded tirzepatide arriving warm in summer months, with policy that places the financial burden on the patient. The cold-chain SOP exists on paper, but third-party logistics failures are documented.
3. $75 non-refundable health-assessment fee is charged before any clinical review and is not refunded on denial, which drives most of the BBB complaint volume per a search-aggregated BBB excerpt.

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 6/10 - partners named, but BPI is 503B and cannot compound tirzepatide post-March 2025
• Adverse Event Response (25%): 2/10 - F BBB plus warm-vial complaints plus nonrefundable-fee disputes
• Cold-Chain & Medication Handling (20%): 3/10 - documented warm-vial failures
• Clinical Oversight (15%): 5/10 - async with licensed provider review
• Marketing & Regulatory Posture (10%): 5/10 - no Lilly suit, but $75 fee plus dose-escalation billing concerns
• Weighted composite: 4.2/10

Includes

• Initial lab test: not specified
• Membership fee: $75 non-refundable health-assessment fee
• Coaching: not specified
• Doctor consultations: async
• Shipping: $10-$25 per order

See Pomegranate Pricing

6. Willow: Lilly Lawsuit Co-Defendant + NAD State-AG Referral

Willow's hormone-coordinated care model is genuinely unique in this lineup, but two regulatory events in the past year have changed the safety calculus. These are allegations only and have not been adjudicated.

Compare Willow Plans

Quick Facts

What I Liked

1. Hormone-coordinated care - the only provider pairing GLP-1 with HRT through the Winona family.
2. BBB-listed (not accredited), no F rating surfaced, per the BBB snapshot used for this audit.
3. Trustpilot 3.7 across 313 reviews; 56% five-star cohort suggests responsive support, per Trustpilot at the time of writing.
4. Women-specific intake tailored to peri- and post-menopausal patients.
5. No FDA warning letter on file.

Room for Improvement

1. Co-defendant in Eli Lilly's April 23, 2025 N.D. Cal. lawsuit alleging deceptive marketing of unapproved compounded tirzepatide. According to the complaint, Willow improperly referenced Lilly's trials. These are allegations only and have not been adjudicated (Lilly v Willow Health Services, N.D. Cal., filed April 23, 2025).
2. NAD referred Willow to state attorneys general in December 2025 after Willow declined to comply with NAD's modification recommendations. Active and unresolved.
3. Sublingual oral tirzepatide tablet is a dosage form never studied in FDA trials. Pharmacokinetics and safety are unknown (FDA, Concerns with Unapproved GLP-1).

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 3/10 - states 503A but does not name partners
• Adverse Event Response (25%): 5/10 - BBB listed, polarized Trustpilot distribution
• Cold-Chain & Medication Handling (20%): 5/10 - undisclosed; no warm-vial complaints surfaced
• Clinical Oversight (15%): 6/10 - women-focused intake screening
• Marketing & Regulatory Posture (10%): 1/10 - Lilly co-defendant plus NAD state-AG referral
• Weighted composite: 3.8/10

Includes

• Initial lab test: not specified
• Membership fee: not specified
• Coaching: not specified
• Doctor consultations: async (women-focused intake)
• Shipping: not specified

Compare Willow Plans

7. MEDVi: F BBB + 311 Complaints + Never-Studied Oral Tablet

MEDVi shows the highest ongoing cost in this lineup at $399/month and the highest BBB complaint count at 311, with a recurring pattern of post-cancellation billing.

Compare MEDVi Plans

Quick Facts

What I Liked

1. Wide product menu that includes both injection and oral tablet formulations.
2. No active Eli Lilly lawsuit at the time of this audit.
3. No FDA warning letter on file.
4. Clinical evaluation is included in the subscription rather than billed separately.
5. Some Trustpilot snapshots outside BBB show mixed 4.4 averages on the .org domain, though the BBB-aggregated Trustpilot rating sits at 1.23/5, per the BBB snapshot used for this audit.

Room for Improvement

1. BBB rating: F. 311 complaints filed. Average BBB review of 1.23/5 across 191 customer reviews, per the BBB snapshot used for this audit.
2. Refund-window reportedly extended from three months to five months between cohorts, with published terms stating in capital letters that no refunds will be issued upon cancellation, per the BBB snapshot used for this audit.
3. Oral tablet GLP-1 dosage form has never been studied in FDA trials. Pharmacokinetics, absorption, and safety are unknown for this delivery route (FDA, Concerns with Unapproved GLP-1).

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 3/10 - partners undisclosed
• Adverse Event Response (25%): 2/10 - F BBB plus 311 complaints plus 1.23/5 BBB Trustpilot
• Cold-Chain & Medication Handling (20%): 5/10 - undisclosed; no warm-vial complaints surfaced
• Clinical Oversight (15%): 4/10 - async, oral tablet option uses unstudied dosage form
• Marketing & Regulatory Posture (10%): 3/10 - no-refund language and oral tablet formulation risk
• Weighted composite: 3.3/10

Includes

• Initial lab test: not specified
• Membership fee: included in $399/month
• Coaching: not specified
• Doctor consultations: async
• Shipping: not specified

Compare MEDVi Plans

8. Eden: F BBB + Documented $576 Product Mix-Up

Eden's bottom-tier ranking is anchored by a documented product mix-up event. A customer paid $576 expecting tirzepatide and received a different drug entirely.

See Eden Pricing

Quick Facts

What I Liked

1. Triple-accredited pharmacy partner per company materials.
2. No active Eli Lilly lawsuit at the time of this audit.
3. No NAD action.
4. Trustpilot page is active with no inauthentic-review notice surfaced, per Trustpilot at the time of writing.
5. Wide formulation menu including MIC and B vitamin add-on options.

Room for Improvement

1. Documented Trustpilot complaint of $576 product mix-up. A customer paid $576 expecting tirzepatide with a B vitamin and instead received MIC plus methylfolate vials. Refund denied on the basis that the medical-evaluation form completed had been for B vitamins. The customer reported having been on tirzepatide for the prior six months. This is a documented product cross-shipment safety event, per Trustpilot at the time of writing.
2. F BBB rating driven primarily by unanswered complaints, per a search-aggregated BBB excerpt; current letter grade not directly fetchable at the time of writing.
3. Pharmacy partners are not publicly named. This is a significant 503A disclosure gap, made more material by the fact that the documented product mix-up event hinged on which pharmacy filled the order.

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 3/10 - partners undisclosed
• Adverse Event Response (25%): 2/10 - F BBB plus documented product mix-up plus refund denial
• Cold-Chain & Medication Handling (20%): 2/10 - the mix-up event is itself a medication-handling failure
• Clinical Oversight (15%): 5/10 - async telehealth
• Marketing & Regulatory Posture (10%): 6/10 - no Lilly suit, no NAD action
• Weighted composite: 3.2/10

Includes

• Initial lab test: not specified
• Membership fee: not specified
• Coaching: not specified
• Doctor consultations: async
• Shipping: not specified

See Eden Pricing

9. Henry Meds: Lead Lilly Defendant + 192 BBB Complaints + Inauthentic Reviews

Henry Meds anchors the bottom of this ranking with the highest concentration of regulatory and consumer-trust signals in the lineup. These are allegations only and have not been adjudicated.

See Henry Meds (review carefully)

Quick Facts

What I Liked

1. Trustpilot 4.5 across 12,000+ reviews, the largest sample in the lineup (read with the inauthentic-review notice below), per Trustpilot at the time of writing.
2. Wide formulation menu including testosterone, semaglutide, and other compounded products.
3. Same-day prescription decisions in many cases.
4. Strong brand recognition and paid-marketing presence.
5. Mobile-friendly intake flow.

Room for Improvement

1. BBB rating: F. 192 complaints in three years. 25 unanswered. Per the BBB snapshot used for this audit, Henry Meds (Adonis Health Inc.) is not accredited and shows a non-response pattern. Themes include $5,501 billed with only $2,728 refunded and a November 2025 refill processed after cancellation confirmation.
2. Trustpilot inauthentic-review-pattern notice active on the Henry Meds page, flagging algorithmic detection of patterns inconsistent with organic review behavior, per Trustpilot at the time of writing. The 4.5 rating cannot be taken at face value.
3. Eli Lilly v. Adonis Health, Inc. d/b/a Henry Meds, 3:25-cv-03536, N.D. Cal., filed April 23, 2025. Lilly alleges Henry Meds "deceives consumers about its untested, unapproved drugs, risking patient safety," and the complaint claims the company sold an oral pill tirzepatide formulation that has never been FDA-approved. In June 2025 the court allowed the unlawful-marketing claim to proceed. These are allegations only and have not been adjudicated.

Safety Sub-Scores (5-axis weighted)

• 503A Compliance & Pharmacy Disclosure (30%): 1/10 - rotating partners, with Lilly's filing asserting a non-compliant oral pill formulation
• Adverse Event Response (25%): 1/10 - F BBB, 192 complaints, 25 unanswered
• Cold-Chain & Medication Handling (20%): 3/10 - rotating partners create inconsistency
• Clinical Oversight (15%): 3/10 - async, with Lilly's filing asserting label-name misrepresentation
• Marketing & Regulatory Posture (10%): 1/10 - Lilly lawsuit plus active Trustpilot inauthentic-review notice
• Weighted composite: 1.8/10

VST recommends Henry Meds patients switch providers, or document every batch and report adverse events to FDA MedWatch.

Includes

• Initial lab test: not specified
• Membership fee: not specified
• Coaching: not specified
• Doctor consultations: async
• Shipping: not specified

See Henry Meds (review carefully)